Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Nov. 01, 2014	Oct. 31, 2015	Nov. 01, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 32,507	$ 28,662	$ 49,905	$ 47,329
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	19,294	19,006	58,169	54,755
Amortization of deferred note expense and debt discount	222	173	604	518
Deferred income taxes	(622)	(8,022)	3,193	(6,413)
Recoveries on accounts receivable	283	317	219	79
Tax indemnification asset write-off	0	7,050	0	7,050
Impairment of long-lived assets	90	397	1,787	1,639
Restricted stock expense	3,550	3,435	10,450	9,943
Provision for discontinued operations	570	144	801	472
Tax benefit of stock options and restricted stock	(30)	(21)	(89)	(3,119)
Other	394	329	1,155	791
Effect on cash from changes in working capital and other assets and liabilities, net of acquisitions:
Accounts receivable	(24,097)	(15,550)	(26,919)	(16,682)
Inventories	(45,797)	(66,219)	(181,524)	(163,339)
Prepaids and other current assets	5,080	12,480	(12,159)	(5,780)
Accounts payable	12,838	7,539	91,757	93,868
Other accrued liabilities	10,175	22,215	(79,322)	41,382
Other assets and liabilities	4,789	(10,902)	6,051	(53,596)
Net cash provided by (used in) operating activities	19,246	1,033	(75,922)	8,897
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(31,525)	(32,580)	(77,796)	(85,317)
Acquisitions, net of cash acquired	0	(31,684)	0	(34,917)
Proceeds from asset sales	21	79	55	235
Net cash used in investing activities	(31,504)	(64,185)	(77,741)	(119,999)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of long-term debt	(5,137)	(3,057)	(17,741)	(10,755)
Proceeds from issuance of long-term debt	0	2,433	27,417	26,253
Borrowings under revolving credit facility	206,037	129,750	288,177	212,950
Payments on revolving credit facility	(98,200)	(88,750)	(111,600)	(150,750)
Tax benefit of stock options and restricted stock	30	21	89	3,119
Share repurchases	(99,120)	(946)	(120,815)	(946)
Change in overdraft balances	(12,676)	2,383	2,503	7,969
Additions to deferred note cost	(16)	0	(655)	0
Exercise of stock options	500	322	1,076	2,009
Other	0	0	0	(42)
Net cash (used in) provided by financing activities	(8,582)	42,156	68,451	89,807
Effect of foreign exchange rate fluctuations on cash	(9)	(281)	493	(126)
Net Decrease in Cash and Cash Equivalents	(20,849)	(21,277)	(84,719)	(21,421)
Cash and cash equivalents at beginning of period	48,997	59,303	112,867	59,447
Cash and cash equivalents at end of period	28,148	38,026	28,148	38,026
Net cash paid (received) for:
Interest	1,140	658	2,065	1,952
Income taxes	$ 5,895	$ (1,202)	$ 39,677	$ 23,775